What is the impact of acquired immunity on the transmission of schistosomiasis and the efficacy of current and planned mass drug administration programmes?
Schistosomiasis causes severe morbidity in many countries with endemic infection with the schistosome digenean parasites in Africa and Asia. To control and eliminate the disease resulting from infection, regular mass drug administration (MDA) is used, with a focus on school-aged children (SAC; 5-14...
Saved in:
Main Authors: | Klodeta Kura (Author), Robert J Hardwick (Author), James E Truscott (Author), Roy M Anderson (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination.
by: Klodeta Kura, et al.
Published: (2019) -
Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis
by: Richards Jr Frank O, et al.
Published: (2006) -
Modeling the interruption of the transmission of soil-transmitted helminths by repeated mass chemotherapy of school-age children.
by: James Truscott, et al.
Published: (2014) -
Individual adherence to mass drug administration in neglected tropical disease control: A probability model conditional on past behaviour.
by: Robert J Hardwick, et al.
Published: (2021) -
Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration.
by: Marleen Werkman, et al.
Published: (2018)